Octreotide and Low-Fat Breast Milk in Postoperative Chylothorax

    loading  Checking for direct PDF access through Ovid

Abstract

Chylothorax is a rare complication following cavo-pulmonary connection and can lead to significant morbidity in infants and young children. We report here the case of a 3-month-old infant who underwent bilateral cavo-pulmonary connections, and developed severe chylothorax refractory to the usual conservative and surgical treatments. His chylothorax resolved after using a combination of parenteral octreotide (Sandostatin, Novartis Pharmaceuticals, East Hanover, NJ) and low-fat breast milk.

Related Topics

    loading  Loading Related Articles